dorsaVi Limited (AU:DVL) has released an update.
dorsaVi Limited has announced the successful validation of its AI Natural Movement Algorithm (AI NMA) against industry gold-standard Vicon, leveraging over 10 years of clinical data. The technology, which has shown promise in chronic spinal pain trials in Europe, is set to revolutionize disability diagnostics by providing clinicians with real-time posture impairment detection and patient insights. This breakthrough positions dorsaVi for commercial expansion into the disability care market, promising to improve patient outcomes and quality of life.
For further insights into AU:DVL stock, check out TipRanks’ Stock Analysis page.
